Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04594798
Title A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Rochester
Indications

diffuse large B-cell lymphoma

follicular lymphoma

B-cell lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Polatuzumab vedotin-piiq + Prednisone + Rituximab

Age Groups: senior
Covered Countries USA

Facility Status City State Zip Country Details
University of Rochester Recruiting Rochester New York 14642 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field